Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2000 November-December;91(11-12) > Minerva Medica 2000 November-December;91(11-12):321-3

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Share

 

CASI CLINICI   

Minerva Medica 2000 November-December;91(11-12):321-3

Copyright © 2000 EDIZIONI MINERVA MEDICA

lingua: Inglese

Hyperpyrexia secondary to acute hypocalcemic status. Is there a role for calcitonin therapy in bone metabolism derangements due to anticonvulsant drugs?

Alexandropoulou P., Mauri D., Rigatou E., Karampoiki V.


PDF


Hypocalcemia, hyperparathyroidism, hypovitaminosis D, hypocalcitoninemia and decreased bone mass are side effects of several anticonvulsant drugs. Since calcitonin inhibits the mineral mobilization of bone and augments minerals bone content, combined therapy with calcitonin, calcium, vitamin-C and vitamin-D was administrated to a patient with severe anticonvulsant disturbances of bone metabolism. Calcitonin hypersensitivity was evident. The symptomatology, characterized by the rare hypocalcemic hyperpyrexia, regressed after calcium infusion.

inizio pagina